Florence Pugh’s Take on Fall’s Most Divisive Shade Is a Historical Bombshell

STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy

Questions about the durability of an experimental Huntington's disease therapy matter to Wall Street. They matter less t…

Alainpaul Spring 2027 Ready-to-Wear